Gene · 6955
Papers2,441
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
581 to 600 of 2,441
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The Impact of Donor and Recipient Genetic Variation on Outcomes After Solid Organ Transplantation: A Scoping Review and Future Perspectives. | Transplantation | 2022 | 34974452 | PubTator, text mining | PubMed |
| Recruitment of highly cytotoxic CD8+ T cell receptors in mild SARS-CoV-2 infection. | Cell Rep | 2022 | 34968416 | PubTator, text mining | PubMed |
| Dechloranes exhibit binding potency and activity to thyroid hormone receptors. | J Environ Sci (China) | 2022 | 34955199 | PubTator, text mining | PubMed |
| Discriminating the origin of calcium oxalate monohydrate formation in kidney stones via synchrotron microdiffraction. | Analyst | 2022 | 34935777 | PubTator, text mining | PubMed |
| Epigenomic translocation of H3K4me3 broad domains over oncogenes following hijacking of super-enhancers. | Genome Res | 2022 | 34933939 | PubTator, text mining | PubMed |
| Genome-wide association study of pain sensitivity assessed by questionnaire and the cold pressor test. | Pain | 2022 | 34924555 | PubTator, text mining | PubMed |
| TIM3+ TRBV11-2 T cells and IFNγ signature in patrolling monocytes and CD16+ NK cells delineate MIS-C. | J Exp Med | 2022 | 34914824 | PubTator, text mining | PubMed |
| IMGT® databases, related tools and web resources through three main axes of research and development. | Nucleic Acids Res | 2022 | 34875068 | PubTator, text mining | PubMed |
| Structure-Guided Approach to Relieving Transcriptional Repression in Resistance to Thyroid Hormone α. | Mol Cell Biol | 2022 | 34871063 | PubTator, text mining | PubMed |
| Sperm associated antigen 7 is activated by T3 during Xenopus tropicalis metamorphosis via a thyroid hormone response element within the first intron. | Dev Growth Differ | 2022 | 34862790 | PubTator, text mining | PubMed |
| Reduced pituitary size in subjects with mutations in the THRB gene and thyroid hormone resistance. | Endocr Connect | 2022 | 34860176 | PubTator, text mining | PubMed |
| An immunodominant NP105-113-B*07:02 cytotoxic T cell response controls viral replication and is associated with less severe COVID-19 disease. | Nat Immunol | 2022 | 34853448 | PubTator, text mining | PubMed |
| Determination of anisotropic elastic parameters from morphological parameters of cancellous bone for osteoporotic lumbar spine. | Med Biol Eng Comput | 2022 | 34843037 | PubTator, text mining | PubMed |
| Biomarkers of DNA Damage Response Enable Flow Cytometry-Based Diagnostic to Identify Inborn DNA Repair Defects in Primary Immunodeficiencies. | J Clin Immunol | 2022 | 34716846 | PubTator, text mining | PubMed |
| Single-cell sequencing unveils distinct immune microenvironments with CCR6-CCL20 crosstalk in human chronic pancreatitis. | Gut | 2022 | 34702715 | PubTator, text mining | PubMed |
| Human stem cell-derived thymic epithelial cells enhance human T-cell development in a xenogeneic thymus. | J Allergy Clin Immunol | 2022 | 34695489 | PubTator, text mining | PubMed |
| Induced pluripotent stem cell-based disease modeling and prospective immune therapy for coronavirus disease 2019. | Cytotherapy | 2022 | 34656419 | PubTator, text mining | PubMed |
| Superior Mesenteric Artery Syndrome Accompanied by Acute-onset Type 1 Diabetes Complicated with Graves' Disease. | Intern Med | 2022 | 34645767 | PubTator, text mining | PubMed |
| Therapeutic cell engineering: designing programmable synthetic genetic circuits in mammalian cells. | Protein Cell | 2022 | 34586617 | PubTator, text mining | PubMed |
| Induced Pluripotent Stem Cells From Subjects With Primary Sclerosing Cholangitis Develop a Senescence Phenotype Following Biliary Differentiation. | Hepatol Commun | 2022 | 34519176 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6955/papers?page=30